01952.HK
Everest Medicines Limited
HKSE · Healthcare · Biotechnology · CN
HKD 27.02
−9.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 26.76x
- P/E 2027E
- 18.83x
- P/E 2028E
- 8.08x
- P/S forward
- 4.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.48x
- Price / sales
- 3.21x
- Price / cash flow
- -42.11x
Enterprise value
- Enterprise value
- HKD 9.0B
- EV / sales
- 3.19x
- EV / EBITDA
- 119.07x
- EV / EBIT
- -60.14x
- Market cap
- HKD 9.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026